VH

Vyome Holdings, Inc.

HINDยทNASDAQ

$5.73

+14%
HealthcareBiotechnology

Vyome Holdings Inc., a clinical-stage healthcare company, develops therapeutic products targeting immuno-inflammatory and rare diseases in the United States and global markets. The company was founded in 2017 and is based in Princeton, New Jersey.

At a Glance

Live Snapshot
Market Cap$151.09M
EPS-345.7400
P/E Ratio-1.29
Earnings Date05/18/2026

No Dividend Yield Data

HIND has not reported any dividend yield values in the available annual periods.

No Dividend Payout Ratio Data

HIND has not reported any dividend payout ratio values in the available annual periods.

No Net Dividends Paid Data

HIND has not reported any net dividends paid values in the available annual periods.

VH

Vyome Holdings, Inc. Dividend History

HIND ยท NASDAQ
10Y CAGR +0%
Latest $0
Annual $0
Stable dividend payments
Last Period: +0%

HIND Dividend Payment History

HIND ยท NASDAQ
DeclarationEx-DatePayment DateDividendAdjustedFrequencyGrowth
No dividend payment history available
h

Vyome Holdings, Inc. Payout Ratio Analysis

HIND ยท NASDAQ
Dividends Paid
0.00
2024
Net Income
-7.13M
2024
Payout Ratio
0.00%
2024

Dividend Sustainability Analysis

Payout Ratio
0.00%

Conservative payout with excellent safety margin. Company retains significant earnings for growth, acquisitions, or building cash reserves. Dividend is highly sustainable.

FCF Payout Ratio
0.0%

Negative free cash flow while paying dividends is a major red flag. Company burning cash and cannot sustain dividend without external financing.

Sustainability
At Risk

Dividend appears unsustainable based on current metrics. High probability of reduction or elimination. Proceed with caution.